According to a new research report by Fact.MR, the global vitreoretinal surgery device market is expected to reach USD 2.23 billion in 2024 and is projected to grow at a CAGR of 6.1% from 2024 to 2034. Advancements in vitreoretinal surgery instruments are significantly improving the precision, safety, and outcomes of these complex procedures.
High-resolution imaging equipment now offers clearer views of retinal structures, while the latest vitreoretinal surgery devices enhance the effectiveness and efficiency of surgical treatments. Techniques like microincision vitrectomy surgery (MIVS) reduce the invasiveness of procedures, leading to faster patient recovery and fewer complications.
Modern laser technology has also enabled more precise targeting and treatment of tissues, contributing to the expansion of the market by providing surgeons with advanced tools that improve success rates and patient outcomes.
For More Insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=10215
Key Takeaways from the Market Study:
- The global vitreoretinal surgery device market is forecasted to reach USD 4.01 billion by the end of 2034.
- Sales of vitrectomy accessories are expected to reach USD 1.53 billion by 2034.
- North America is estimated to hold a 41.1% share of the global market in 2024.
- The U.S. market is projected to reach USD 916 million by 2034.
- Sales of vitreoretinal surgery devices in Japan are estimated at USD 114 million in 2024, with projections reaching USD 231 million by the end of 2034.
- Demand for vitreoretinal surgery devices in Mexico is expected to grow at a 6% CAGR through 2034.
- The retinal detachment application segment is poised to hold a 27.7% market share in 2024.
- Hospitals are expected to generate USD 2 billion in revenue by the end of 2034.
Leading Players Innovating in the Vitreoretinal Surgery Device Market
- Hoya Surgical Optics
- Rodenstock
- Topcon Corporation
- Alcon Inc.
- Cooper Vision
- British Virgin Islands (BVI)
- Johnson & Johnson Vision Care, Inc.
- Erbe Elektromedizin
- Safilo Group
- Carl Zeiss Meditec AG
- Blink Medical
- Nidek Co., Ltd.
Rising Demand for Vitreoretinal Surgery Devices in Japan
Japan has seen a rise in diabetes cases, leading to an increased risk of diabetes-related retinopathy, which often requires vitreoretinal surgery. The growing demand for advanced surgical therapies to manage diabetic retinopathy is driving the need for vitreoretinal surgical devices in Japan, contributing to the country’s heightened focus on improving eye care standards.
Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=10215
Competitive Landscape
Leading companies in the vitreoretinal surgery device market are focused on developing innovative treatments for retinal detachment and expanding the applications of vitrectomy. Technological advancements remain a key differentiator for market leaders.
Vitreoretinal Surgery Device Industry News:
- In December 2023, Carl Zeiss Meditec announced its acquisition of the Dutch Ophthalmic Research Center to expand its range of ophthalmic equipment, including vitreoretinal surgery devices. The transaction, valued at approximately USD 1.07 billion, is expected to be completed in 2024.
- Ellex Medical Lasers launched its new minimally invasive EYESYS 23G Vitrectomy technology in June 2022, offering surgeons more precise and efficient vitreoretinal surgery tools.
More Valuable Insights Available
Fact.MR’s latest report provides an in-depth analysis of the vitreoretinal surgery device market from 2019 to 2023, along with forecast statistics for 2024 to 2034. The study covers market insights based on product type (vitrectomy accessories, vitrectomy packs, vitrectomy machines, disposables), application (diabetic vitreous hemorrhage, retinal detachment, macular hole), and end user (hospitals, eye clinics, ASCs) across seven major regions: North America, Western Europe, Eastern Europe, East Asia, Latin America, South Asia & Pacific, and the Middle East & Africa.